Riparian Pharmaceuticals
Latest round
- Series A
Last raised
- Oct 2018
Total raised
- $3M
Investors
- 3
About Riparian Pharmaceuticals
Founded in 2012 and based in Massachusetts, US, Riparian Pharmaceuticals, Inc. is a biotechnology company that researches and develops novel therapies using models of pathophysiology, to treat vascular diseases. The company cooperates with Brigham & Women’s Hospital, and the Biotech Community. Mr. Will Adams is the CEO and founder of the company. The company provides vascular health therapeutics for vascular diseases.
Who invested in Riparian Pharmaceuticals
3 investors across 1 round
See all investors in Riparian Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 12, 2018
Amount
$3M
Investors
Questions about Riparian Pharmaceuticals
Who invested in Riparian Pharmaceuticals?
Riparian Pharmaceuticals has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Riparian Pharmaceuticals raised?
Riparian Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Riparian Pharmaceuticals last raise money?
Riparian Pharmaceuticals's most recent round on record is a Series A, in Oct 2018.
What does Riparian Pharmaceuticals do?
Founded in 2012 and based in Massachusetts, US, Riparian Pharmaceuticals, Inc.
Where is Riparian Pharmaceuticals headquartered?
Riparian Pharmaceuticals is headquartered in Boston, US.
Which VCs invest in companies like Riparian Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Riparian Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Riparian Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.